insights_auto
Zašto je ALMKT pao 2,79%?
Istražite detaljnijechevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,087 €
arrow_downward
−2,79%(−0,0025) 1D
20. stu, 17:35:11 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALMKT...
Otvori
0,09 €
Najviša
0,09 €
Najniža
0,09 €
Trž. kap.
16,66 mil.
Prosj. kol.
406,96 tis.
Količina
258,62 tis.
P/E omjer
0,74
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Otvori
0,09 €
Najviša
0,09 €
Najniža
0,09 €
Trž. kap.
16,66 mil.
Prosj. kol.
406,96 tis.
Količina
258,62 tis.
P/E omjer
0,74
52-tjed. najviša
0,23 €
52-tjed. najniža
0,07 €
EPS
0,12 €
Dionice u optjecaju
195,26 mil.
Broj djelatnika
56
Vijesti
Iz web-izvora i od partnera za vijesti
WSJ
·
prije 1 dan
Dow, S&P 500 Poised to Close at a Correction
Yahoo Finance
·
prije 5 sati
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
24/7 Wall St.
·
prije 7 sati
The S&P 500 Is Now Below Every Wall Street Year-End Target for 2026
Beinsure
·
prije 12 sati
Dow Jones today: What’s next for stocks in 2027 after an 8% weekly crash?
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA – informacije
Glavni izvršni direktorSacha Loiseau
Zaposlenici56
Osnovano2000
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijamaunakeatech.com